Nestlé to Acquire IM HealthScience

Nestlé Health Science has agreed to acquire the business of IM HealthScience with its brands of IBgard®, FDgard®, Fiber Choice® and REMfresh®.

“The IMH products offer proven and trusted solutions for the dietary management of specific digestive problems as well as a separate solution for regulating sleep,” said Greg Behar, CEO of Nestlé Health Science. “IMH’s dedication to developing products to address overall health and wellness by bringing cutting-edge life science and world-class research fits perfectly with our mission of empowering healthier lives through nutrition.”

IMH is the innovator of IBgard® and FDgard® for the dietary management of Irritable Bowel Syndrome and Functional Dyspepsia, respectively. In 2017, IMH added Fiber Choice®, a line of prebiotic fibers, to its product line via an acquisition. REMfresh® is a continuous release-and-absorption melatonin (CRA-melatonin) supplement for sleep.